A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is
Int J Clin Exp Med
Objective: This study aimed to investigate the potential value of serum miR-203 as noninvasive recurrence -predictive and prognostic biomarker in patients with papillary thyroid carcinoma (PTC). Methods: 165 patients received total thyroidectomy in Ningbo No. 2 Hospital from June, 2008 to September, 2014 were enrolled in this study. Serum expressions of miR-203 were evaluated from the obtained blood samples from all the PTC patients by quantitative real-time PCR. The association between serumfatcat:zba3bmc5qnbshjs4ifeyyutvbe